期刊文献+

慢性稳定型心绞痛的中西医疗法疗效观察 被引量:4

Clinical observation on treating chronic stable angina in the integrative medicine
下载PDF
导出
摘要 目的:探讨活血化瘀中成药联合抗血小板药阿司匹林在慢性稳定型心绞痛治疗方面的疗效。方法:选取我院84例慢性稳定型心绞痛患者作为此次研究的样本,随机分为对照组与观察组。对于对照组只采用中医疗法,即只使用通心络胶囊;对于观察组采用活血化瘀中成药联合阿司匹林的治疗方法。结果:经治疗,对照组有效人数为32例,有效率为76.2%;相比对照组,观察组有效率为88.1%,高于对照组的76.2%。观察组在心绞痛发作次数、每次发作持续时间方面均优于对照组,且差异均有统计学意义(P<0.05)。结论:运用活血化瘀中成药联合抗血小板药的方法在慢性稳定型心绞痛治疗方面更具优势。 Objective: To investigate the efficacy of Huoxue Huayu TCM medicine combined with antiplatelet agents Aspirin on treating chronic stable angina. Methods: 84 cases of chronic stable angina were chosen as samples, which were randomly divided into control group and observation group. For the control group, using only TCM medicine treatment; for the observation group, besides using TCM medicine treatment, we also use the aspirin. Results: After treatment, the control group effective in 32 cases, efficiency was 76.2%. Compared to the control group, efficiency of observation group was 88.1%, which was higher than that of control group, which was 76.2%. Otherwise, observation group in angina attack frequency, duration of each episode are better than the control group, and the differences were statistically significant (P〈0.05). Conclusion: The using of TCM medicine combined with antiplatelet agents in patients with chronic stable angina is effective.
作者 高娃
出处 《中医临床研究》 2014年第2期101-102,共2页 Clinical Journal Of Chinese Medicine
关键词 慢性稳定型心绞痛 活血化瘀 抗血小板 Chronic stable angina Huoxue Huayu Antiplatelet
  • 相关文献

参考文献4

二级参考文献11

  • 1心血管疾病介入诊疗技术管理规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(2):76-78. 被引量:15
  • 2田友谊.通心脉汤治疗冠心病稳定性心绞痛62例[J].河南中医,2005,25(8):39-39. 被引量:6
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2093
  • 4Stergiopoulos K, Brown D L. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease~ meta--analysis of randomized controlled trials[J]. Arch Intern Med,2012,172(4):312- 319.
  • 5Shaw L J, Berman D S, Maron D J, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ische- mic burden: results from the Clinical Outcomes Utilizing Revascu- larization and Aggressive Drug Evaluation (COURAGE) trial nu- clear substudy[J].Circulation, 2008,117(10) : 1283 - 1291.
  • 6Weintraub W S, Spertus J A, Kolm P, et al. Effect of PCI on qual- ity of life in patients with stable coronary disease[J].N Engl J Med, 2008,359(7) :677-687.
  • 7Myers W O, Davis K, Foster E D, et al. Surgical survival in the Coronary Artery Surgery Study (CASS) registry[J].Ann Thorac Surg, 1985,40(3) : 245 - 260.
  • 8中华医学会心血管病学分会介人心脏病学组,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012,40(4):271-277.
  • 9Serruys P W, Morice M C, Kappetein A P, et al. Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Severe Coronary Artery Disease[J].N Eng J Med,2009,360:961 -972.
  • 10Task Force on Myocardial Revascularization of the European Socie- ty of Cardiology (ESC) and the European Association for Cardio-- Thoracic Surgery (EACTS), European Association for Percutane- ous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guide lines on myocardial revascularization [J]. Eur Heart J, 2010, 31 (20) :2501-2555.

共引文献15

同被引文献37

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部